199 related articles for article (PubMed ID: 19809836)
1. Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells.
Zhai S; Yang L; Cui QC; Sun Y; Dou QP; Yan B
J Biol Inorg Chem; 2010 Feb; 15(2):259-69. PubMed ID: 19809836
[TBL] [Abstract][Full Text] [Related]
2. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
Daniel KG; Chen D; Orlu S; Cui QC; Miller FR; Dou QP
Breast Cancer Res; 2005; 7(6):R897-908. PubMed ID: 16280039
[TBL] [Abstract][Full Text] [Related]
3. Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer.
Daniel KG; Chen D; Yan B; Dou QP
Front Biosci; 2007 Jan; 12():135-44. PubMed ID: 17127289
[TBL] [Abstract][Full Text] [Related]
4. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
5. Synchrotron X-ray imaging reveals a correlation of tumor copper speciation with Clioquinol's anticancer activity.
Barrea RA; Chen D; Irving TC; Dou QP
J Cell Biochem; 2009 Sep; 108(1):96-105. PubMed ID: 19530227
[TBL] [Abstract][Full Text] [Related]
6. Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells.
Milacic V; Jiao P; Zhang B; Yan B; Dou QP
Int J Oncol; 2009 Dec; 35(6):1481-91. PubMed ID: 19885572
[TBL] [Abstract][Full Text] [Related]
7. Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.
Daniel KG; Gupta P; Harbach RH; Guida WC; Dou QP
Biochem Pharmacol; 2004 Mar; 67(6):1139-51. PubMed ID: 15006550
[TBL] [Abstract][Full Text] [Related]
8. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
[TBL] [Abstract][Full Text] [Related]
9. Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
Viola-Rhenals M; Rieber MS; Rieber M
Biochem Pharmacol; 2006 Mar; 71(6):722-34. PubMed ID: 16412983
[TBL] [Abstract][Full Text] [Related]
10. Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents.
Oliveri V; Lanza V; Milardi D; Viale M; Maric I; Sgarlata C; Vecchio G
Metallomics; 2017 Oct; 9(10):1439-1446. PubMed ID: 28932850
[TBL] [Abstract][Full Text] [Related]
11. Development of a copper-clioquinol formulation suitable for intravenous use.
Wehbe M; Malhotra AK; Anantha M; Lo C; Dragowska WH; Dos Santos N; Bally MB
Drug Deliv Transl Res; 2018 Feb; 8(1):239-251. PubMed ID: 29247315
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity.
Gobec M; Kljun J; Sosič I; Mlinarič-Raščan I; Uršič M; Gobec S; Turel I
Dalton Trans; 2014 Jun; 43(24):9045-51. PubMed ID: 24781711
[TBL] [Abstract][Full Text] [Related]
13. Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation.
Tardito S; Barilli A; Bassanetti I; Tegoni M; Bussolati O; Franchi-Gazzola R; Mucchino C; Marchiò L
J Med Chem; 2012 Dec; 55(23):10448-59. PubMed ID: 23170953
[TBL] [Abstract][Full Text] [Related]
14. Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs.
Oliveri V; Giuffrida ML; Vecchio G; Aiello C; Viale M
Dalton Trans; 2012 Apr; 41(15):4530-5. PubMed ID: 22354329
[TBL] [Abstract][Full Text] [Related]
15. Molecular study on copper-mediated tumor proteasome inhibition and cell death.
Xiao Y; Chen DI; Zhang X; Cui Q; Fan Y; Bi C; Dou QP
Int J Oncol; 2010 Jul; 37(1):81-87. PubMed ID: 20514399
[TBL] [Abstract][Full Text] [Related]
16. Clioquinol promotes cancer cell toxicity through tumor necrosis factor alpha release from macrophages.
Du T; Filiz G; Caragounis A; Crouch PJ; White AR
J Pharmacol Exp Ther; 2008 Jan; 324(1):360-7. PubMed ID: 17940196
[TBL] [Abstract][Full Text] [Related]
17. Clioquinol - a novel copper-dependent and independent proteasome inhibitor.
Schimmer AD
Curr Cancer Drug Targets; 2011 Mar; 11(3):325-31. PubMed ID: 21247386
[TBL] [Abstract][Full Text] [Related]
18. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
[TBL] [Abstract][Full Text] [Related]
19. Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma.
Mao X; Li X; Sprangers R; Wang X; Venugopal A; Wood T; Zhang Y; Kuntz DA; Coe E; Trudel S; Rose D; Batey RA; Kay LE; Schimmer AD
Leukemia; 2009 Mar; 23(3):585-90. PubMed ID: 18754030
[No Abstract] [Full Text] [Related]
20. PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study.
Summers KL; Dolgova NV; Gagnon KB; Sopasis GJ; James AK; Lai B; Sylvain NJ; Harris HH; Nichol HK; George GN; Pickering IJ
Metallomics; 2020 Dec; 12(12):1979-1994. PubMed ID: 33169753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
